LaserAway, Nation's Largest Aesthetic Dermatology Brand, Opens Its 223rd Clinic

Why this matters

The expansion of LaserAway to its 223rd clinic underscores a notable trend in institutional commercial real estate: the growing appeal of specialized health and wellness operators as stable tenants. Aesthetic dermatology, positioned at the intersection of elective healthcare and lifestyle services, has demonstrated resilience amid broader retail and office market volatility. This milestone signals sustained consumer demand and operational scalability within the sector, factors that increasingly attract private equity and institutional capital seeking income diversification beyond traditional CRE asset classes. From a capital-markets perspective, the continued rollout of clinics by a founder-led brand suggests confidence in both the underlying real estate locations and the sector’s cash flow durability. For landlords and lenders, such tenants offer a hedge against the cyclical pressures facing conventional retail, given the recurring nature of medical service visits and the demographic tailwinds supporting wellness spending. The geographic choice—expanding in a secondary market like Garland, TX—also reflects the strategic targeting of growth corridors outside of saturated coastal metros, aligning with broader institutional shifts toward Sun Belt and suburban nodes. In sum, LaserAway’s clinic growth exemplifies how health-focused service providers are reshaping CRE demand patterns, influencing underwriting criteria, and recalibrating portfolio allocations within US institutional real estate.

Editorial analysis · AI-assisted

External link. Real Estate Trail does not republish source content.